The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs).
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche
 
Pilar Garcia-Alfonso
No Relationships to Disclose
 
Jose María Vieitez
Consulting or Advisory Role - Roche, Amgen, Servier
Research Funding - Amgen; Roche
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche; SERVIER
 
Maria Jose Ortiz
No Relationships to Disclose
 
Carlos López-López
Honoraria - AstraZeneca; Bayer; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Eisai; Ipsen; Merck; Pfizer; Roche; Sanofi; Servier
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Eisai (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck; Pfizer; Roche; SERVIER
 
Juan José Reina-Zoilo
Consulting or Advisory Role - Amgen; Archimedes; Bayer; Ipsen; Merck; Novartis; Pfizer; Prostrakan; Roche; Sanofi; Servier
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Merck; Novartis; Prostrakan; Roche; Sanofi; SERVIER
 
Antonieta Salud Salvia
No Relationships to Disclose
 
Guillermo Alfonso Quintero Aldana
No Relationships to Disclose
 
Luis Robles
No Relationships to Disclose
 
Maria Jose Safont
No Relationships to Disclose
 
Adelaida La Casta Munoa
Travel, Accommodations, Expenses - Amgen; Amgen
 
Inmaculada Alés
No Relationships to Disclose
 
Eduardo Polo Marques
No Relationships to Disclose
 
Javier Gallego Plazas
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Roche
Speakers' Bureau - Amgen; Ipsen; Lilly
Travel, Accommodations, Expenses - Amgen; Novartis
 
Beatriz García de Paredes
No Relationships to Disclose
 
Rafael Lopez
Stock and Other Ownership Interests - MTrap; Nasasbiotech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; lilly; MSD; Roche
Speakers' Bureau - Novartis; Roche
Research Funding - Lilly (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Roche; Tesaro
 
Guillot Mónica
No Relationships to Disclose
 
Manuel Valladares-Ayerbes
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Merck; Roche; SERVIER
Consulting or Advisory Role - Amgen; Merck; Sanofi
Speakers' Bureau - Bayer; Roche; SERVIER
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; Roche; SERVIER
 
Javier Sastre
No Relationships to Disclose
 
Eduardo Díaz-Rubio
Consulting or Advisory Role - Amgen; Bayer; Genomica; Merck Serono; Servier
Speakers' Bureau - MSD; SERVIER
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck Serono (Inst); Roche (Inst); Sysmex (Inst)